Get the tools used by (smart)2 investors.

Revenue Per Share CAGR (3y) for Eli Lilly and Company

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

LLY: Eli Lilly and Company

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, H...

738.21 USD
Price
USD
Fair Value
Upside
711.40 - 972.53
52-week range

Analysis

How does Eli Lilly's Revenue Per Share CAGR (3y) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Eli Lilly and Company because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Revenue Per Share CAGR (3y)

Hide this widget
rev_share_cagr_3y
Slug
number
Datatype
text
Format
current
Default Period
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Revenue Per Share CAGR (3y) in the growth category include:

View Full List

Search for metric or datapoint

Revenue Per Share CAGR (3y)

Three-year compound annual growth rate in revenue per share.

Definition of Revenue Per Share CAGR (3y)

Hide this widget
Three-year compound annual growth rate in revenue per share.

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-79.3%-14.3%50.7%164.7%0100200

The chart above depicts the distribution of revenue per share cagr (3y) for companies operating in the Healthcare sector in the Developed economic region. Over 1,580 companies were considered in this analysis, and 1,518 had meaningful values. The average revenue per share cagr (3y) of companies in the sector is 1.7% with a standard deviation of 35.1%.

Eli Lilly and Company's Revenue Per Share CAGR (3y) of 17.0% ranks in the 79.0% percentile for the sector. The following table provides additional summary stats:

Revenue Per Share CAGR (3y) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents1,582
Included Constituents1,518
Min-83.1%
Max160.5%
Median3.5%
Mean1.7%
Standard Deviation35.1%

You can find companies with similar revenue per share cagr (3y) using this stock screener.

All rights reserved. Terms Of Use